Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

BAX

BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 10456Held by 11 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$11.24B
Net Income FY2025
$(0.96B)
EPS (Basic, as reported)
$-1.87
Net Margin FY2025
-8.5%
ROE FY2025
-15.6%
Total Equity
$6.13B
Shares Out
517M
Business description

BAXTER INTERNATIONAL INC — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 10,163 → 11,244 +1.1% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue10,16310,56111,12711,36211,67312,78415,11314,81310,63611,244
Cost of revenue(6,053)(6,099)(6,346)(6,601)(7,086)(7,679)(9,716)(9,838)(6,652)(7,865)
Gross profit4,1104,4624,7814,7614,5875,1055,3974,9753,9843,379
Research & development(647)(617)(655)(595)(521)(534)(605)(667)(590)(518)
Selling, general & administrative(2,739)(2,587)(2,617)(2,535)(2,469)(2,867)(3,887)(3,946)(2,967)(2,890)
Operating income7241,2581,5991,7721,6161,710(1,943)39014(308)
Interest expense(89)(85)(93)(111)(153)(206)(415)(512)(408)(290)
Interest & investment income23304840191420706752
Other income (expense), net4,29614139(731)(190)(41)(15)(51)3841
Pre-tax income4,9541,2171,6939701,2921,477(2,353)(103)(289)(505)
Income tax expense(12)(493)(63)(41)(182)(182)(68)(34)(37)(395)
Net income4,9657171,6241,0011,1021,284(2,433)2,656(649)(957)
EPS — basic$9.09$1.32$3.04$1.97$2.17$2.56($4.83)$5.25($1.27)($1.87)
EPS — diluted$9.01$1.29$2.97$1.93$2.13$2.53($4.83)$5.25($1.27)($1.87)
Shares outstanding — basic (M)546543534509509502504506510513
Shares outstanding — diluted (M)551555546519517508504506510513

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.